PHARMIX
ActiveSummary
The computed 12-month bankruptcy probability of PHARMIX is 1.5% (moderate). The 2025 annual accounts show negative equity (-€348,800) and a net result of -€475,283. Equity is shrinking by about 33% per year across the filed financial years. Its solvency ranks better than 6% of 9,602 sector peers (NACE 46, financial year 2025). The company has been active since 1981 and the Belgian Official Gazette contains no insolvency or warning signals.
Group and network
Connections & network
The network starts from this company’s shareholders. What else they own or run appears here as nodes.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.